SCHEMBL13736459

SCHEMBL13736459

CCCCN(C(=O)O)C1CNCC(C)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.35
SIGMAR1 Q99720 2/20 0.35
KDM5A P29375 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
CYP3A4 P08684 1/20 0.31
PYGL P06737 1/20 0.31
CTSD P07339 1/20 0.31
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
PTBP1 P26599 1/20 0.30
CHRNB2 P17787 1/20 0.30
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA7 P36544 1/20 0.30
CHRNA4 P43681 1/20 0.30
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA9 Q16790 1/20 0.30
SLC6A2 P23975 1/20 0.30
SLC6A4 P31645 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28246290 0.78 SLC6A2 (0.47) SLC6A2SLC6A4
SCHEMBL3821799 0.78 SLC6A2 (0.47) SLC6A2SLC6A4
SCHEMBL1221462 0.78 SLC6A2 (0.47) SLC6A2SLC6A4
SCHEMBL2875169 0.75 SLC6A2 (0.41) L3MBTL1LMNASLC6A2SLC6A4
SCHEMBL17786300 0.75 SLC6A2 (0.41) L3MBTL1LMNASLC6A2SLC6A4
SCHEMBL1612684 0.75 L3MBTL1 (0.39) L3MBTL1SIGMAR1CYP3A4ALDH1A1LMNA
SCHEMBL2304116 0.74 SIGMAR1 (0.39) L3MBTL1SIGMAR1CYP3A4ALDH1A1LMNA
SCHEMBL3818321 0.73 SLC6A4 (0.44) L3MBTL1SIGMAR1SLC6A2SLC6A4
SCHEMBL22236152 0.73 L3MBTL1 (0.35) L3MBTL1SIGMAR1KDM5AKDM4CCTSD
SCHEMBL18704813 0.73 SLC6A2 (0.46) SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2702063-A1 BICYCLIC PYRIDAZINE COMPOUNDS AS PIM INHIBITORS Amgen Inc. (US) 2014-03-05 EP disclosed
WO-2012148775-A1 BICYCLIC PYRIDAZINE COMPOUNDS AS PIM INHIBITORS AMGEN INC. (US) 2012-11-01 WO disclosed